Study raises important questions about the clinical utility of multicancer early detection testing

This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, a trial shows that testing increased early‐stage cancer detection but did not significantly reduce late‐stage diagnoses. In addition, the FDA has approved an all‐oral regimen for older patients with AML who are ineligible for intensive chemotherapy, and tile‐based radiation therapy may be the new standard of care for patients with surgical brain metastases.